The Management of Hypertension for an Acute Stroke: What Is the Blood Pressure Goal?

Hypertension (M Sorrentino, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Hypertension

Abstract

Stroke is the 4th leading cause of death in the US and a leading cause of disability among adults. Stroke is broadly classified into ischemic and hemorrhagic subtypes. Although the pathogenesis may differ between ischemic and hemorrhagic stroke subtypes, a unifying feature is that hypertension is a major risk factor for most ischemic and hemorrhagic strokes. Prevention of first and recurrent stroke is substantially dependent on blood pressure control. There is controversy about blood pressure management in acute stroke. In this review we discuss controversies about and guidelines for management of blood pressure in acute stroke. We subdivide our discussion to address important questions about acute blood pressure management in ischemic stroke, intraparenchymal hemorrhage, and subarachnoid hemorrhage. In addition, we address BP control recommendations when tissue plasminogen activator administration is being contemplated for treatment of acute ischemic stroke.

Keywords

Blood pressure Hypertension Acute stroke Ischemic stroke Hemorrhagic stroke Mean arterial pressure Guidelines 

Notes

Conflict of Interest

Philip B. Gorelick has received grant support from H. Lundbeck as the Co-Director of Clinical Coordinating Center for US DIAS 4 Trial (desmoteplase in acute ischemic stroke); has received honoraria from both Brainsgate and DPharm, on which he is a Steering Committee Member; and he has received payment for development of educational presentations including service on speakers' bureaus from the American Academy of Neurology.

Venkatesh Aiyagari has received grant support from the World Federation of Neurology and World Stroke Association; and has received royalty from Springer for co-editing a monograph on stroke and hypertension.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Gorelick PB, Ruland S. Cerebral vascular disease. Disease-a-Month. 2010;56:33–100.CrossRefGoogle Scholar
  2. 2.
    Testai FD, Gorelick PB. Potential for stroke prevention. In: Spence D, Barnett HJM, editors. Stroke prevention, treatment & rehabilitation. New York: McGraw Hill; 2012. p. 22–38.Google Scholar
  3. 3.
    Hypertension and Stroke. In: Aiyagari V, Gorelick PB, editors. New York: Humana; 2011. p. 3–279.Google Scholar
  4. 4.
    Goldstein LB. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004;43:137–41.PubMedCrossRefGoogle Scholar
  5. 5.
    Owens WB. Blood pressure control in acute cerebrovascular disease. J Clin Hypertens. 2011;13:205–2011.CrossRefGoogle Scholar
  6. 6.
    Symon L, Crockhard HA, Dorsch NW, Branston NM, Juhasz J. Local cerebral blood flow and vascular reactivity in chronic stable stroke in baboons. Stroke. 1975;6:482–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Jordan JD, Powers WJ. Cerebral autoregulation and acute ischemic stroke. Am J Hypertens. 2012;25:946–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Powers WJ, Videen TO, Diringer MN, Aiyagari V, Zazulia AR. Autoregulation after ischemic stroke. J Hypertens. 2009;27:2218–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Aiyagari V, Gorelick PB. Management of blood pressure for acute and recurrent stroke. Stroke. 2009;40:2251–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.PubMedCrossRefGoogle Scholar
  11. 11.
    Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMedCrossRefGoogle Scholar
  12. 12.
    Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315–20.PubMedCrossRefGoogle Scholar
  13. 13.
    Menon RS, Burgess RE, Wing JJ, Gibbons MC, Shara NM, Fernandez S, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol. 2012;71:199–205.PubMedCrossRefGoogle Scholar
  14. 14.
    Prabhakaran S, Naidech AM. Ischemic brain injury after intracerebral hemorrhage. A critical review. Stroke. 2012;43:2258–63.PubMedCrossRefGoogle Scholar
  15. 15.
    •• Diringer MN, Bleck TP, Hemphill III CJ, Menon D, Shutter L, et al. Critical Care Management of Patients Following AneurysmalSubarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40. A guideline for critical care management of aneurysmal subarachnoid hemorrhage that includes recommendations for blood pressure control.PubMedCrossRefGoogle Scholar
  16. 16.
    Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomized, placebo-controlled double-blind trial. Lancet. 2011;377:741–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study. Evaluation of acute candesartan cilixetil therapy in stroke survivors. Stroke. 2003;34:1699–703.PubMedCrossRefGoogle Scholar
  18. 18.
    Robinson TG, Potter JF, Ford GA, Bulpitt C, Chernova J, Jagger C, et al. Effects of antihypertensive Collaborative Study (COSSACS): a prospective, randomized, open, blinded-endpoint trial. Lancet Neurol. 2010;9:767–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomized, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8:38–56.CrossRefGoogle Scholar
  20. 20.
    • Gorelick PB. Is reduction of blood pressure in acute stroke justified? Lancet Neurol. 2011;10:295–6. An editorial comment about the pros and cons of blood pressure lowering in acute ischemic stroke and addresses the question of whether blood pressure lowering is justified.PubMedCrossRefGoogle Scholar
  21. 21.
    Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral hemorrhage trial (INTERACT): a randomized, pilot trial. Lancet Neurol. 2008;7:391–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5:110–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559–76.PubMedCrossRefGoogle Scholar
  24. 24.
    •• Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick FP, Connolly ES, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29. A major American Heart Association guideline on brain hemorrhage that includes blood pressure lowering management recommendations.PubMedCrossRefGoogle Scholar
  25. 25.
    •• Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–33. A major American Heart Association guideline on aneurysmal subarachnoid hemorrhage that includes blood pressure lowering management recommendations.PubMedCrossRefGoogle Scholar
  26. 26.
    Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655–711.PubMedCrossRefGoogle Scholar
  27. 27.
    •• Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. doi:10.1161/STR.0b013e318284056a. A major American Heart Association guideline for acute ischemic stroke that includes blood pressure lowering management recommendations.PubMedCrossRefGoogle Scholar
  28. 28.
    Kang J, Ko Y, Park JH, Kim W-J, Jang MS, Yang MH, et al. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology. 2012;79:2018–24.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Hauenstein Neuroscience Center, Saint Mary’s Health Care, Translational Science & Molecular MedicineMichigan State University College of Human MedicineGrand RapidsUSA
  2. 2.Neurological Surgery and Neurology & Neurotherapeutics, Division of Neurocritical CareUT Southwestern Medical CenterDallasUSA

Personalised recommendations